Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Haemophilia Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Haemophilia Treatmentmarket, defines the market attractiveness level of Haemophilia Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Haemophilia Treatment industry, describes the types of Haemophilia Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Haemophilia Treatment market and the development prospects and opportunities of Haemophilia Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Haemophilia Treatment market in Chapter 13.
By Player:
Alnylam Pharmaceuticals
Shire
Roche
Catalyst BioSciences
Dimension Therapeutics
Novo Nordisk
Pfizer
CSL Behring
Aptevo Therapeutics
Bayer
By Type:
Haemophilia A
Haemophilia B
By End-User:
Hospital
Pharmaceutical Companies
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Haemophilia Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Haemophilia Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Haemophilia Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Haemophilia Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Haemophilia Treatment Market Analysis and Outlook to 2022
-
7.1 Global Haemophilia Treatment Consumption (2017-2022)
-
7.2 United States Haemophilia Treatment Consumption (2017-2022)
-
7.3 Europe Haemophilia Treatment Consumption (2017-2022)
-
7.4 China Haemophilia Treatment Consumption (2017-2022)
-
7.5 Japan Haemophilia Treatment Consumption (2017-2022)
-
7.6 India Haemophilia Treatment Consumption (2017-2022)
-
7.7 South Korea Haemophilia Treatment Consumption (2017-2022)
8 Region and Country-wise Haemophilia Treatment Market Analysis and Outlook to 2028
-
8.1 Global Haemophilia Treatment Consumption Forecast (2022-2028)
-
8.2 United States Haemophilia Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Haemophilia Treatment Consumption Forecast (2022-2028)
-
8.4 China Haemophilia Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Haemophilia Treatment Consumption Forecast (2022-2028)
-
8.6 India Haemophilia Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Haemophilia Treatment Consumption Forecast (2022-2028)
9 Global Haemophilia Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Haemophilia Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Haemophilia A Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Haemophilia B Consumption and Growth Rate (2017-2022)
-
9.2 Global Haemophilia Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Haemophilia Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Haemophilia Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Haemophilia A Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Haemophilia B Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Haemophilia Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Haemophilia Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Haemophilia Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Haemophilia Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Haemophilia Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Haemophilia Treatment Market Competitive Analysis
-
14.1 Alnylam Pharmaceuticals
-
14.1.1 Alnylam Pharmaceuticals Company Details
-
14.1.2 Alnylam Pharmaceuticals Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Alnylam Pharmaceuticals Haemophilia Treatment Product and Service
-
14.2 Shire
-
14.2.1 Shire Company Details
-
14.2.2 Shire Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Shire Haemophilia Treatment Product and Service
-
14.3 Roche
-
14.3.1 Roche Company Details
-
14.3.2 Roche Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Haemophilia Treatment Product and Service
-
14.4 Catalyst BioSciences
-
14.4.1 Catalyst BioSciences Company Details
-
14.4.2 Catalyst BioSciences Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Catalyst BioSciences Haemophilia Treatment Product and Service
-
14.5 Dimension Therapeutics
-
14.5.1 Dimension Therapeutics Company Details
-
14.5.2 Dimension Therapeutics Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Dimension Therapeutics Haemophilia Treatment Product and Service
-
14.6 Novo Nordisk
-
14.6.1 Novo Nordisk Company Details
-
14.6.2 Novo Nordisk Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novo Nordisk Haemophilia Treatment Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Haemophilia Treatment Product and Service
-
14.8 CSL Behring
-
14.8.1 CSL Behring Company Details
-
14.8.2 CSL Behring Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 CSL Behring Haemophilia Treatment Product and Service
-
14.9 Aptevo Therapeutics
-
14.9.1 Aptevo Therapeutics Company Details
-
14.9.2 Aptevo Therapeutics Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Aptevo Therapeutics Haemophilia Treatment Product and Service
-
14.10 Bayer
-
14.10.1 Bayer Company Details
-
14.10.2 Bayer Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bayer Haemophilia Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Haemophilia Treatment
-
Figure Haemophilia Treatment Picture
-
Table Global Haemophilia Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Haemophilia Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Haemophilia Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Haemophilia Treatment Consumption by Country (2017-2022)
-
Figure United States Haemophilia Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Haemophilia Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Haemophilia Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Haemophilia Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Haemophilia Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Haemophilia Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Haemophilia Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Haemophilia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Haemophilia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Haemophilia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Haemophilia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Haemophilia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Haemophilia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Haemophilia A Consumption and Growth Rate (2017-2022)
-
Figure Global Haemophilia B Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Haemophilia A Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Haemophilia B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Haemophilia Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Haemophilia Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals Haemophilia Treatment Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Haemophilia Treatment Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Haemophilia Treatment Product and Service
-
Table Catalyst BioSciences (Foundation Year, Company Profile and etc.)
-
Table Catalyst BioSciences Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Catalyst BioSciences Haemophilia Treatment Product and Service
-
Table Dimension Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Dimension Therapeutics Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dimension Therapeutics Haemophilia Treatment Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Haemophilia Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Haemophilia Treatment Product and Service
-
Table CSL Behring (Foundation Year, Company Profile and etc.)
-
Table CSL Behring Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Behring Haemophilia Treatment Product and Service
-
Table Aptevo Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Aptevo Therapeutics Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aptevo Therapeutics Haemophilia Treatment Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Haemophilia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Haemophilia Treatment Product and Service
-
